
Italy · Medical devices startup
StarTric is a medical device startup based in Milan, Italy, founded in 2020.
Funding reportedLast round: Series A
Follow StarTric and see its new rounds in your feed.Start following
StarTric is a medical device startup based in Milan, Italy, founded in 2020.
The company focuses on innovative cardiovascular technologies, particularly in structural heart interventions. With a small team of experts, including co-founders Prof. Ottavio Alfieri and Prof. Michele De Bonis, StarTric is developing a transcatheter tricuspid valve repair device. This device aims to replicate the Clover technique, a proven surgical method, through a minimally invasive approach. Led by CEO Daniele Zanotti and COO & CFO Eugenio Passanante, StarTric is in the development phase, having completed feasibility studies and prototype testing in animal models. The company is working towards regulatory approval and plans to enter clinical trials. StarTric's mission is to provide effective treatment for tricuspid regurgitation, addressing a significant unmet need in cardiovascular care. The company emphasizes safety, efficacy, and accessibility, aiming to improve outcomes for patients worldwide.
Funding, as reported
What they build
Known for
health careedge-to-edge repairclinical needdevice implantation at beating heartcardiologytransfemoral catheter deliverysurgical risk reductionhospital & health careminimally invasive devicemedicalsurgical technique adaptationspecific anatomy repairhealthsurgical technique replicationtransfemoral cathetermedical devices
Built with from their website
Google CloudViewport MetawebpackGoogle Cloud HostingPriority HintsReactMicrosoft ExchangeSirvoyWix eCommerceMicrosoft 365 Apps & Services
WebsiteBuilderMobile FriendlyLodashOpen GraphGoogle Cloud CDNHTTP/3WixSentry
Add your raise, your deck and your story, and put StarTric in front of investors. Or tell us what we have wrong.